Laparoscopy-assisted creation of a liver failure model in pigs

Cell Transplantation

Volumn 17, Issue 1-2, 2008, Pages 187-193

  Yuasa, Takeshi ^a   Yamamoto, Tsuyoshi ^a   Rivas Carrillo, Jorge D ^a   Chen, Yong ^a   Navarro Alvarez, Nalú ^a   Soto Guiterrez, Alejandro ^a   Noguchi, Hirofumi ^b,c   Matsumoto, Shinichi ^b,c   Tanaka, Noriaki ^a   Kobayashi, Naoya ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Baylor All Saints Islet Cell Laboratory   (United States)

^c BAYLOR RESEARCH INSTITUTE   (United States)

Author keywords

Carbon tetrachloride; Hepatic failure; Laparoscopy; Pigs

Indexed keywords

CARBON TETRACHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BIOARTIFICIAL LIVER; CELL THERAPY; CONFERENCE PAPER; FEMALE; HEMODYNAMICS; HEPATIC ARTERY LIGATION; HEPATOCYTE TRANSPLANTATION; LAPAROSCOPY; LIVER BIOPSY; LIVER FAILURE; LIVER ISCHEMIA; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; REPRODUCIBILITY; SURVIVAL TIME; SWINE;

ANIMALIA; SUIDAE;

EID: 42249110527     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000008783906973     Document Type: Conference Paper

References (22)

1. Bismuth, H.; Samuel, D.; Berneau, J.; Gugenheim, J.; Castaing, D.; Rueff, B.; Benhamou, J. P. Emergency liver transplantation: A breakthrough in the treatment of fulminant hepatitis. J. Hepatol. 5:S12; 1987.
2. Brems, J. J.; Hiath, J. R.; Ramming, K. P.; Quinones, B. W. J.; Busuttil, R. W. Fulminant hepatic failure. The role of liver transplantation as primary therapy. Am. J. Surg. 154:137-141; 1987.
3. Christensen, E.; Bremmelgaard, A.; Bahnsen, M.; Andreason, P. B.; Tygstrup, N. Prediction of fatality in fulminant hepatic failure. Scand. J. Gastroenterol. 19:90-96; 1984.
4. Demetriou, A. A.; Brown, R. S.; Busuttil, R. W.; Fair, J.; McGuire, B. M.; Rosenthal, P. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann. Surg. 239:660-670; 2004.
5. Detry, O.; Arkadopoulos, N.; Ting, P. Clinical use of a bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure. Am. Surg. 65:934-938; 1999.
6. Ellis, A. J.; Hughes, R. D.; Wendon, J. A. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 24:1446-1451; 1996.
7. Enosawa, S.; Miyashita, T.; Saito, T.; Omasa, T.; Matsumura, T. The significant improvement of survival times and pathological parameters by bioartificial liver with recombinant HepG2 in porcine liver failure model. Cell Transplant. 15:873-880; 2006.
8. Fausto, N. Liver regeneration. J. Hepatol. 32(Suppl. 1): 19-31; 2000.
9. Gandillet, A.; Vidal, I.; Alexandre, E.; Audet, M.; Chenard-Neu, M. P.; Stutzmann, J.; Heyd, B.; Jaeck, D.; Riehen, L. Experimental models of acute and chronic liver failure in nude mice to study hepatocyte transplantation. Cell Transplant. 14:277-290; 2005.
10. Horslen, S. P.; Hammel, J. M.; Fristoe, L. W. Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation 70:1472-1478; 2000.
11. Ito, M.; Nagata, H.; Yamamoto, T.; Yoshihara, D.; Fox, I. J.; Miyakawa, S. Intrasplenic hepatocyte transplantation prolonged the survival in Nagase analbuminemic rats with liver failure induced by common bile duct ligation. Cell Transplant. 16:547-553; 2007.
12. Kobayashi, N.; Okitsu, T.; Nakaji, S.; Tanaka, N. Hybrid bioartificial liver: Establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J. Artif. Organs 6:236-244; 2003.
13. Lee, K. U.; Zheng, L. X.; Cho, Y. B.; Kim, K. H.; Ha, J.; Suh, K. S.; Jung, S. E. An experimental animal model of fulminant hepatic failure in pigs. J. Korean Med. Sci. 20:427-432; 2005.
14. Mathiesen, L. R.; Skinoj, R.; Nielsen, J. O.; Purcell, R. H.; Wong, D.; Ranek, L. Hepatitis type A, B, and non-A non-B in fulminant hepatitis. Gut 21:72-77; 1980.
15. Mullon, C.; Pitkin, Z. The HepatAssist® Bioartificial Liver Support System: Clinical study and pig hepatocyte process. Exp. Opin. Invest. Drugs 8:229-235; 1999.
16. Nieuwoudta, M.; Kunnikeb, R.; Smutsc, M.; Beckerd, J.; Stegmanne, G. F.; Waltb, C. V.; Neserf, J.; Merweb, S. V. Standardization criteria for an ischemic surgical model of acute hepatic failure in pigs. Biomaterials 27:3836-3845; 2006.
17. Soto-Gutierrez, A.; Kobayashi, N.; Rivas-Carrillo, J. D.; Navarro-Alvarez, N.; Zhao, D.; Okitsu, T.; Noguchi, H.; Basma, H.; Tabata, Y.; Chen, Y.; Tanaka, K.; Narushima, M.; Miki, A.; Ueda, T.; Jun, H. S.; Yoon, J. W.; Lebkowski, J.; Tanaka, N.; Fox, I. J. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat. Biotechnol. 24:1412-1419; 2006.
18. Terblanche, J.; Hickman, R. Animal models of fulminant hepatic failure. Dig. Dis. Sci. 36:770-774; 1991.
19. van de Kerkhove, M. P.; Ernesto, D. F.; Vincenzo, S. Bridging a patient with acute liver failure to liver transplantation by the AMC-bioartificial liver. Cell Transplant. 12:563-568; 2003.
20. van de Kerkhove, M. P.; Hoekstraa, R.; Gulika, T. M.; Chamuleau, R. A. F. M. Large animal models of fulminant hepatic failure in artificial and bioartificial liver support research. Biomaterials 25:1613-1625; 2004.
21. Vickers, C.; Neuberger, J.; Buckels, J.; McMaster, P.; Elias, E. Transplantation of the liver in adults and children with fulminant hepatic failure. J. Hepatol. 7:143-150; 1988.
22. Watanabe, F. D.; Mullon, C. J.; Hewitt, W. R.; Arkadopoulos, N.; Kahaku, E.; Eguchi, S.; Khalili, T.; Arnaout, W.; Shackleton, C. R.; Rozga, J.; Solomon, B.; Demetriou, A. A. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg. 225:484-494; 1997.